Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
Market Analysis and Insights: Global Adoptive Cell Therapy Market
In 2019, the global Adoptive Cell Therapy market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Adoptive Cell Therapy Scope and Market Size
Adoptive Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Adoptive Cell Therapy market is segmented into CAR-T, TCR-T, NK, TIL, etc.
Segment by Application, the Adoptive Cell Therapy market is segmented into Lymphoma, Leukemia, etc.
Regional and Country-level Analysis
The Adoptive Cell Therapy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Adoptive Cell Therapy market report are North America, Europe, China, Japan, South Korea and India, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Adoptive Cell Therapy Market Share Analysis
Adoptive Cell Therapy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Adoptive Cell Therapy business, the date to enter into the Adoptive Cell Therapy market, Adoptive Cell Therapy product introduction, recent developments, etc.
The major vendors include Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum, etc.

This report focuses on the global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.

The key players covered in this study

Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum

Market segment by Type, the product can be split into

CAR-T
TCR-T
NK
TIL

Market segment by Application, split into

Lymphoma
Leukemia

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
South Korea
India

The study objectives of this report are:

To analyze global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adoptive Cell Therapy are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.